Compare CCCC & ANTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCCC | ANTA |
|---|---|---|
| Founded | 2015 | 2022 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.4M | 227.5M |
| IPO Year | 2020 | 2025 |
| Metric | CCCC | ANTA |
|---|---|---|
| Price | $2.15 | $9.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.25 | ★ $17.50 |
| AVG Volume (30 Days) | ★ 1.6M | 4.3K |
| Earning Date | 02-26-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 669.18 |
| EPS | N/A | ★ 0.47 |
| Revenue | $30,108,000.00 | ★ $65,033,103.00 |
| Revenue This Year | N/A | $69.27 |
| Revenue Next Year | N/A | $64.32 |
| P/E Ratio | ★ N/A | $19.41 |
| Revenue Growth | N/A | ★ 63.28 |
| 52 Week Low | $1.09 | $8.50 |
| 52 Week High | $3.84 | $27.72 |
| Indicator | CCCC | ANTA |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 45.34 |
| Support Level | $2.06 | $8.87 |
| Resistance Level | $2.23 | $9.99 |
| Average True Range (ATR) | 0.15 | 0.32 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 32.99 | 32.34 |
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.
Antalpha Platform Holding Co provides financing, technology and risk management solutions to the digital asset industry. It is a provider of supply chain financing solutions to institutional and corporate participants in the Bitcoin mining industry, offering loans secured by Bitcoin and Bitcoin mining machines. It has developed a technology platform, Antalpha Prime, which enables customers to apply for and manage their digital asset loans while allowing to closely monitor collateral positions.